NO965445L - Ny 4-imidazolidinonforbindelse, fremgangsmåte ved dens fremstilling og farmasöytiske sammensetninger inneholdende den - Google Patents

Ny 4-imidazolidinonforbindelse, fremgangsmåte ved dens fremstilling og farmasöytiske sammensetninger inneholdende den

Info

Publication number
NO965445L
NO965445L NO965445A NO965445A NO965445L NO 965445 L NO965445 L NO 965445L NO 965445 A NO965445 A NO 965445A NO 965445 A NO965445 A NO 965445A NO 965445 L NO965445 L NO 965445L
Authority
NO
Norway
Prior art keywords
new
preparation
pharmaceutical compositions
compositions containing
imidazolidinone compound
Prior art date
Application number
NO965445A
Other languages
English (en)
Other versions
NO305753B1 (no
NO965445D0 (no
Inventor
Alex Cordi
Jean-Michel Lacoste
Mark Millan
Valerie Audinot
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO965445D0 publication Critical patent/NO965445D0/no
Publication of NO965445L publication Critical patent/NO965445L/no
Publication of NO305753B1 publication Critical patent/NO305753B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO965445A 1995-12-21 1996-12-18 Ny 4-imidazolidinonforbindelse, fremgangsmÕte ved dens fremstilling og farmas°ytiske sammensetninger inneholdende den NO305753B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515223A FR2742748B1 (fr) 1995-12-21 1995-12-21 Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui le contiennent

Publications (3)

Publication Number Publication Date
NO965445D0 NO965445D0 (no) 1996-12-18
NO965445L true NO965445L (no) 1997-06-23
NO305753B1 NO305753B1 (no) 1999-07-19

Family

ID=9485771

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965445A NO305753B1 (no) 1995-12-21 1996-12-18 Ny 4-imidazolidinonforbindelse, fremgangsmÕte ved dens fremstilling og farmas°ytiske sammensetninger inneholdende den

Country Status (14)

Country Link
US (1) US5677325A (no)
EP (1) EP0780379B1 (no)
JP (1) JPH09176128A (no)
CN (1) CN1067381C (no)
AT (1) ATE165349T1 (no)
AU (1) AU705695B2 (no)
CA (1) CA2193310C (no)
DE (1) DE69600253T2 (no)
DK (1) DK0780379T3 (no)
ES (1) ES2118664T3 (no)
FR (1) FR2742748B1 (no)
NO (1) NO305753B1 (no)
NZ (1) NZ299984A (no)
ZA (1) ZA9610804B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6347197B1 (en) * 2000-10-20 2002-02-12 Lexmark International, Inc. Life determination in an oil web system
JP3891484B2 (ja) * 2002-09-05 2007-03-14 株式会社ノリタケカンパニーリミテド 電解質膜およびその膜を備えた燃料電池

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers

Also Published As

Publication number Publication date
NO305753B1 (no) 1999-07-19
DE69600253D1 (de) 1998-05-28
CN1067381C (zh) 2001-06-20
DK0780379T3 (da) 1999-01-25
FR2742748B1 (fr) 1998-01-30
AU7547996A (en) 1997-06-26
CN1158847A (zh) 1997-09-10
FR2742748A1 (fr) 1997-06-27
CA2193310C (fr) 2001-08-14
ZA9610804B (en) 1997-06-30
US5677325A (en) 1997-10-14
JPH09176128A (ja) 1997-07-08
ATE165349T1 (de) 1998-05-15
NO965445D0 (no) 1996-12-18
DE69600253T2 (de) 1998-11-12
AU705695B2 (en) 1999-05-27
EP0780379A1 (fr) 1997-06-25
EP0780379B1 (fr) 1998-04-22
CA2193310A1 (fr) 1997-06-22
NZ299984A (en) 1997-11-24
ES2118664T3 (es) 1998-09-16

Similar Documents

Publication Publication Date Title
EP0368388A3 (en) 3-Piperidinyl-1,2-benzisoxazoles
ES2054826T3 (es) Peptidos con actividad inhibidora de colagenasa.
PT96916A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um macrolido
PT77110B (fr) Procede de preparation de nouveaux derives de la xanthine
BR9813669A (pt) Mistura fungicida, e, processo para controlar fungos nocivos
DE69327890D1 (de) Verfahren zur Herstellung von 2-(un)substituierten 4-Alkylimidazolen
MX9300875A (es) Procedimiento para la preparacion de compuestos azabiciclicos.
EP0144991A3 (en) Polymethosybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
NO965445L (no) Ny 4-imidazolidinonforbindelse, fremgangsmåte ved dens fremstilling og farmasöytiske sammensetninger inneholdende den
ES2030242T3 (es) Procedimiento para la obtencion de cetonas alfa, beta-insaturadas.
HU903092D0 (en) Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
PT80791A (fr) Procede de preparation de nouvelles phenyl-naphtiridines utiles notamment comme medicaments anti-ulceres
DK232883D0 (da) Fremgangsmade til fremstilling af optisk aktive imidazolylpropanolforbindelser
ATE60048T1 (de) Aminoverbindungen und diese enthaltende fungizide.
NO905521L (no) 2-formylbenzylfosfonsyre-derivater, deres fremstilling oganvendelse til behandling av sykdommer som er foraarsaket av virus.
DE3469527D1 (en) Nortropine derivative, process for its preparation and its use
NO972291L (no) Fremgangsmåte for fremstilling av optisk aktive forbindelser
SE8203245L (sv) Forfarande for enantioselektiv framstellning av n-substituerade prolinderivat
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
PT1098901E (pt) Novos derivados da 6-desoxi eritromicina seu processo de preparacao e sua aplicacao como medicamentos
TH7859EX (th) อนุพันธ์ต่างๆของพิริโดนคาร์บอกซิลิคแอซิดชนิดออพทิคัลลีแอคทีฟ
TH7168A (th) สารประกอบชนิดใหม่